Replay of the Next Generation Medtech & Device Panel,
 8th Annual HealthTech Investment Forum

Pixium Vision is pleased to share the Next Generation Medtech & Device Panel, which took place at 8th Annual HealthTech Investment Forum.

Chaired by:
Diana Saraceni, Co-Founder & General Partner, Panakès Partners SGR SpA

Panelists:
Ian Crosbie, CEO, Sequana Medical NV
Jeffrey Scott Cohen, Managing Director, Equity Research, Healthcare & Medical Technologies, Ladenburg Thalmann & Co. Inc.
Jonathan Goldstein, Director, Global Tech Partnerships, Boston Scientific
Lloyd Diamond, President & CEO, PIXIUM VISION SA
Mike Karim, CEO, Oxford Endovascular Ltd.
Rupert Winckler, Head of EMEA Business Development, Olympus Europa SE & Co. KG

2021-11-09T16:31:43+01:00November 9th, 2021|Conferences, News|

Presentation on Thursday, October 21, 2021 during 2nd Annual DryAMD Therapeutic Development Summit

Ralf Hornig, Director of Clinical Affairs, presented at the 2nd Annual Dry AMD Therapeutic Development Summit the long-term visual results of the Prima chip in patients with geographic atrophy.

2nd-Annual-Dry-AMD-Therapeutic-Development-Virtual-Event

2021-10-22T09:59:42+02:00October 21st, 2021|Conferences, News|

Demy-Colton Virtual Salon Series – Ophthalmic Drug Delivery: Eye on Innovation on July 28, 2021

Panel Ophthalmic Drug Delivery: Eye on Innovation July 28, 2021

Sara Demy, CEO of Demy-Colton, hosts interactive virtual salons featuring industry leaders and distinguished guests exploring today’s most consequential and disruptive topics in healthcare.

Ophthalmic Drug Delivery: Eye on Innovation
Innovative biotech companies are racing to develop unique drug-delivery systems and agents that overcome the many obstacles that have limited the treatment of serious and increasingly common eye problems. Our panelists will outline the trajectory of this industry’s growth and give an overview of the technologies that are advancing it. Many new ocular drug-transport systems and formulations are being designed as noninvasive, early, and more patient-friendly treatments. Our panelists will also provide insight into bringing these treatments from lab to clinical study and market.

2021-07-27T02:09:31+02:00July 26th, 2021|Conferences, Events, News|

Replay of the Key Opinion Leader on the Prima System for dry-AMD

Pixium Vision’s key opinion leader on the Prima System for Atrophic Dry Age-related Macular Degeneration (dry-AMD). In case you were unable to attend or would like to hear all or part of it again, the replay of the event is now available online: https://www.pixium-vision.com/KOL-Call-October-2020/

The webinar featured a presentation by José-Alain Sahel, M.D., University of Pittsburgh School of Medicine, Lisa C. Olmos de Koo, M.D., University of Washington and Ralf Hornig, Director of Clinical Affairs, who discussed the current treatment landscape and unmet medical need of Advanced Atrophic dry-AMD. They also shared their experience on how the Prima system is helping their patients regain autonomy and quality of life. Dr Yannick Le Mer and Dr Joseph Martel joined to answer questions following the formal presentation.The Pixium Vision management team also gave an update on the Prima System which has the potential to address this significant unmet medical need in dry-AMD.

2020-11-04T14:26:51+01:00November 4th, 2020|Conferences, Events, News|

Friday, October 30th, 2020 10:30 AM EDT – Join us for the KOL Call on the Prima System for Atrophic Dry Age-related Macular Degeneration (dry-AMD)

Please join us for the Pixium Vision S.A. KOL Call on the Prima System for Atrophic Dry Age-related Macular Degeneration (dry-AMD) featuring José-Alain Sahel, M.D. (University of Pittsburgh School of Medicine) and Lisa C. Olmos de Koo, M.D. (University of Washington) who will discuss the current treatment landscape and unmet medical need in treating patients with Advanced Atrophic Dry Age-related Macular Degeneration (dry-AMD). A question and answer session will follow the formal presentations.

2020-11-03T16:39:37+01:00October 28th, 2020|Conferences, Events, News|
Go to Top